About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05930626

Biomarkers of Acrylamide, Glycidol, POPs, PFAS and Disease Outcomes and OMICs Signatures

The aim of the project is to assess the associations between biomarkers of acrylamide and glycidol exposure and disease outcomes in a case-cohort study based on two prospective cohorts with biobanks. ...

Lead sponsor: Karolinska Institutet•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Karolinska Institutet

Collaborators

The Swedish Research Council

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•60YO: Men and women of 60 years old residing in Stockholm
•SMC-C: Women residing in Uppsala

Exclusion Criteria

•Subjects will be excluded if they had the outcome under investigation at baseline

Related studies

RECRUITINGPhase 3

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

NCT06274047 · Androgen Axis Suppression, Prostatectomy, and more

RECRUITINGPhase 3

Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease

NCT07571161 · Alzheimer Disease

Data Collection Protocol for Patients With Von Hippel Lindau Disease

NCT05955014 · Von Hippel Lindau Disease

RECRUITINGPhase 2

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

NCT07271186 · Diabetic Kidney Disease (DKD)

Screening for Research Participants

NCT00655096 · Eye Diseases

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 5, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment9,254

Start dateJan 1997

Last updatedJul 5, 2023

Condition

Disease Cardiovascular Diseases Cancer Environmental Exposure

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 5, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions